[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 2, 2007

Mortality and Adherence to Pharmacotherapy After Acute Myocardial Infarction

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(17):1877-1878. doi:10.1001/jama.297.17.1877-a

To the Editor: In their study of adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction (AMI), Dr Rasmussen and colleagues1 suggest that the relationship between high adherence and lower mortality is due to an active drug effect rather than to a “healthy adherer” effect. Adherence to placebo has also been associated with lower mortality,2 suggesting that other factors may also be important. One of these factors may be depression, since depression is associated with poor adherence3 and with increased mortality after MI.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×